All products are for laboratory research purposes only. Not for human consumption.
Buying guide
Peptide Blends and Bundles
A blend fixes the ratio of its components across a batch and removes a reconstitution step. It does not make them work better together, and we say so on every blend page.
The short version
- Four blends, all boxes of 10 vials. Wolverine at $119.28, CJC-1295 + Ipamorelin at $119.28, GLOW at $170.71, KLOW at $185.00. Each is co-lyophilised in a single vial with a batch-specific Certificate of Analysis.
Buying
What a blend actually changes
A practical comparison of the four blends in this catalogue. Nothing here is a claim that combining compounds produces an effect greater than the components, and no published study has tested these specific combinations.
Wolverine: BPC-157 and TB-500
Five milligrams of each, co-lyophilised. These are the two most requested compounds in the catalogue and the pairing is the most common in the research-chemical market. The reasoning is mechanistic rather than experimental: growing new blood vessels and moving cells into damaged tissue are different steps in the same repair sequence. No published study has tested the two together.
GLOW and KLOW: the difference is one component
GLOW is BPC-157 10 mg, GHK-Cu 50 mg and TB-500 10 mg. KLOW is the same three plus KPV 10 mg. That single difference is the whole distinction between them, and it is worth knowing before paying the higher price for KLOW. Both are catalogued under skin and cosmetic research because GHK-Cu anchors them.
CJC-1295 + Ipamorelin: the one with published support for the pairing
This is the only blend here where the principle behind combining the components has been tested in humans. Giving a GHRH analogue together with a growth-hormone-releasing peptide produces a larger growth hormone response than either class alone. The synergy work used GHRP-class peptides rather than ipamorelin specifically, and the 5 mg to 5 mg ratio is a market convention, but the mechanism is not merely asserted.
What a blend does not do
Fixing a ratio is a formulation decision. It makes every vial in a batch identical and removes a reconstitution step from the bench, which is a real convenience. It is not evidence of synergy. A supplier claiming these blends work better than their components is describing an expectation, not a finding.
Common questions
Which blend should I choose?
It depends on whether your work needs the components separately. A blend fixes the ratio; separate vials let you vary it. If you are comparing GLOW and KLOW, the only difference is KPV.
Are blends cheaper than buying the components?
Not necessarily, and that is not the reason to buy one. The reason is a fixed ratio across a batch and one reconstitution step instead of several. Compare against the individual product pages, all of which publish price per vial.
Do any of these have published trials?
The combinations do not. The individual components have their own literature, which is set out on each product page. CJC-1295 + Ipamorelin is the only one where the class-level pairing has human evidence behind it.